8 СПИСОК ЛИТЕРАТУРЫ

1. Андреев С.М., Бабахин А.А., Петрухина А.О. и др. Иммуногенные и аллергенные свойства коньюгатов фуллерена с аминокислотами и белком // ДАН.

- 2000. - Т.370, № 2 . - С.261-264.

2. Арчаков А.И. Микросомальное окисление. - М.: Наука. - 1975. - С.327.

3. Виноградова Л.В., Меленевская Е.Ю., Хачатуров А.С и др. Водорастворимые комплексы фуллерена С₆₀ с поли-Ы-инилпирролидоном // Высокомол. соед.-

1998. - Т.40. - С.1854-1862.

4. Гмошинский И.В., Смирнова В.В., Хотимченко С.А. Современное состояние проблемы оценки безопасности наноматериалов //Российские нанотехнологии. - 2010. - Т.5, № 9-10. - С.6-10.

5. Голубкина Н.А. Флуориметрический метод определения селена // Журн. аналитической химии. - 1995. - Т.50, № 8. - С.492-497.

6. Елецкий А.В., Смирнов Б.М. Фуллерены и структуры углерода // Успехи физических наук. - 1995. - Т.165, № 9. - С.977-1009.

7. Западнюк И.П., Западнюк В.И., Захария Е.А. Лабораторные животные, их разведение, содержание и использование в эксперименте. - Киев: Медгиз УССР. - 1962. - 180 с.

8. Захаренко Л.П., Захаров И.К., Васюнина Е.А. и др. Определение генотоксичности фуллерена C60 и фуллерола методом соматических озаиков на клетках крыла Drosophila melanogaster и в SOS-хромотесте // Генетика. - 1997. - Т.33. - С.405-409.

9. Кулинский В.И. Активные формы кислорода и оксидативная модификация макромолекул: польза, вред и защита // Соросовский образовательный журн. -

1999. - № 1. - С.2-7.

10. Меньшиков В.В. Лабораторные методы исследования в клинике. Справочник. - М.: Медицина. - 1987. - 368 с.

11. Мазо В.К., Гмошинский И.В., Саблина В.В. и др. Проницаемость стенки тонкой кишки для белковых антигенов у человека и лабораторных животных // Вопросы питания. - 2008. - Т.77, № 2. - С.10-21.

12. Микроскопическая техника: Руководство / Под ред. Саркосова Д.Л. и Перова Ю.Л. - М.: Медицина, 1996.

13. Онищенко Г.Г., Тутельян В.А. О концепции токсикологических исследований, методологии оценки риска, методов идентификации и количественного определения наноматериалов // Вопросы питания. - 2007. - Т.76, № 6. - С.4-8.

14. Онищенко Г.Г., Тутельян В.А., Гмошинский И.В. и др. Развитие системы оценки безопасности и контроля наноматериалов и нанотехнологий в Российской Федерации // Гигиена и санитария. - 2013. - № 1. - С.4-11.

15. Первушин Ю.В., Рогова С.Ш., Ковалевич Н.И. и др. Лабораторные методы исследования системы гемостаза и диагностика нарушений системы гемокоагуляции. Учебное пособие. Ставрополь-Москва. Издательство Москва. -

2009. - 60 с.

16. Перцов С.С., Коплик Е.В., Калиниченко Л.С. Сравнительный анализ действия цитокинов на состояние тимуса, надпочечников и селезенки у крыс с разными поведенческими характеристиками // Бюллетень экспериментальной биологии и медицины. - 2010. - №9. - С. 244-247.

17. Пестова М.И., Гмошинский И.В., Мазо В.К. Влияние потребления молока на активность системы детоксикации формальдегида при сенсибилизации этим соединением // Вопросы питания. - 1992. - № 5-6. - С.41-44.

18. Пиотровский Л.Б., Еропкин М.Ю., Еропкина Е.М. и др. Механизмы биологического действия фуллеренов - зависимость от агрегатного состояния // Психофармакология и биологическая наркология. - 2007. - № 2. - С.1548-1554.

19. Пиотровский Л.Б., Киселёв О.И. Фуллерены в биологии // СПб: ООО Издательство «Росток». - 2006. - 336 с.

20. Пиотровский Л.Б., Киселев О.И., Кезелецкая К.Н. и др. Противовирусная активность фуллерена С₆₀ в комплексе с поли(Ы-винилпирролидоном) // ДАН. -

1998. - Т.361, № 4. - С.547- 549.

21. Хотимченко С.А., Гмошинский И.В., Тутельян В.А. Проблема обеспечения безопасности наноразмерных объектов для здоровья человека // Гигиена и санитария. - 2009. - № 5. - С.7-11.

22. Ali Ansari-Lari M., Kickler T.S., Borowitz M.J. Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis // Am.

23. Andrievsky G., Klochkov V., Derevyanchenko L. Is C60 fullerene molecule toxic? // Fullerenes, Nanotubes, Carbon Nanostruct. - 2005. - V.13. - P.363-376.

24. Aoshima H., Yamana S., Nakamura S. et al. Biological safety of water-soluble fullerenes evaluated using tests for genotoxicity, phototoxicity, and pro-oxidant activity // J Toxicol Sci. - 2010. - Vol.35, N.3. - P.401-409.

25. Avanasi R., Jackson W.A., Sherwin B. et al. C60 fullerene soil sorption, biodegradation, and plant uptake // Environ Sci Technol. - 2014. - Vol.48, N.5. - P.2792-7.

26. Baati T., Bourasset F., Gharbi N. et al. The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene // Biomaterials. - 2012. - Vol.33, N.19. - P.4936-46.

27. Baierl Т., Drosselmeyer E., Seidel A., Hippeli S. Comparison of immunological effects of fullerene C60 and raw soot from fullerene production on alveolar macrophages and macrophage like cells in vitro // Exp. Toxicol. Pathol. - 1996. - V.48. - P.508-511.

28. Baker G.L., Gupta A., Clark M.L. et al. Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles // Toxicol. Sci. - 2008. - V.101, N.1. - P.122-131.

29. Bakry R., Vallant R.M., Najam-ul-Haq M. et al. Medicinal applications of fullerenes // Int. J. Nanomedicine. - 2007. - N. 2(4). - P.639-649.

30. Baron J.L., Reich E.P., Visintin I. et al. The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell

adhesion molecule-1 // The Journal of clinical investigation. - 1994. - V.93. - N.4. - P.1700-1708.

31. Baun A., Sorensen S.N., Rasmussen R.F. et al. Toxicity and bioaccumulation of xenobiotic organic compounds in the presence of aqueous suspensions of aggregates of nano-C₆₀// Aquat. Toxicol. - 2008. - V.86, N.3. - P.379-387.

32. Behrens I., Pena A.I., Alonso M.J. et al. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport // Pharm.

33. Blickley T.M., McClellan-Green P. Toxicity of aqueous fullerene in adult and larval fundulus heteroclitus // Environ. Toxicol. Chem. - 2008. - V.24, N.1.

34. Borbala D., Gabor K., McAleer F.M. et al. In vivo radioprotection by the fullerene nanoparticle DF-1as assessed in a Zebrafish model // Clin. Cancer Res. - 2006. - V.12, N.23.

35. Braun Т., Buvari-Barcza A., Barcza L. et al. Mechanochemistry: a novel approach to the synthesis of fullerene compounds. Water soluble buckminster-fullerene-y- cyclodextrin inclusion complexes via a solid-solid reaction // Solid State Ionics. - 1994. - V.74. - P.47-51.

36. Brunet L., Lyon D.Y., Hotze E.M. et al. Comparative photoactivity and antibacterial properties of C60 fullerenes and titanium dioxide nanoparticles. Environ Sci Technol. - 2009. - Vol.43, N.12. - P.4355-4360.

37. Cagle D.W., Kennel S.J., Mirzadeh S. et al. In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers // Proc Natl Acad Sci USA. -

1999. - Vol.96, N.9. P.5182-7.

38. Cai X., Hao J., Zhang X. et al. The polyhydroxylated fullerene derivative C60(OH)24 protects mice from ionizing-radiation-induced immune and mitochondrial dysfunction // Toxicol Appl Pharmacol. - 2010. - Vol.243, N.1. - P.27-34.

39. Canesi L., Ciacci C., Vallotto D. et al. In vitro effects of suspensions of selected nanoparticles (C60 fullerene, TiO2, SiO2) on Mytilus hemocytes. // Aquat Toxicol. -

2010. - Vol.96, N.2. - P.151-158.

40. Canesi L., Fabbri R., Gallo G. et al. Biomarkers in Mytilus galloprovincialis exposed to suspensions of selected nanoparticles (Nano carbon black, C60 fullerene, Nano-TiO(2), Nano-SiO(2)) // Aquat Toxicol. - 2010. - Vol.100, N.2. P.168-77.

41. Carter R.A., Wicks I.P. Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation // Arthritis and rheumatism. - 2001. - V.44. - N.5. - P.985-94.

42. Cataldo F. Solubility of fullerenes in fatty acids esters: a new way to deliver in vivo fullerenes.

43. Chang X., Ruan L., Yang S. et al. Quantification of carbon nanomaterials in vivo: direct stable isotope labeling on the skeleton of fullerene C60 // Environ. Sci. - 2014. - Vol.1. - P.64-70.

44. Chen C., Xing G., Wang J. et al. Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity // Nano. Lett. - 2005. - V.5, N.10. - P.2050-2057.

45. Chen H.H., Yu C., Ueng T.H. et al. Acute and subacute toxicity study of water­soluble polyalkylsulfonated C60 in rats // Toxicol. Pathol. - 1998. - V.26, N.1. - P.143- 151.

46. Cheng X., Каn А. Т., Tomson M. B. Naphthalene adsorbtion and desorption from aqueous C60, fullerene // J. Chem. Eng. Data. - 2004. - V.49. - P.675-683.

47. Chiron J., Lamande J., Moussa F. et al. Effect of «micronized» C60 fullerene on the microbial growth in vitro // Ann. Pharm. Fr. - 2000. - V.58. - P. 170-175.

48. Cook S.M., Aker W.G., Rasulev B.F. et al. Choosing safe dispersing media for C60 fullerenes by using cytotoxicity tests on the bacterium Escherichia coli // J Hazard Mater. - 2010. - Vol.176, N.1-3. - P.367-373.

49. Deguchi S., Yamazaki T., Mukai S.A. et al. Stabilization of C60 nanoparticles by protein adsorption and its implications for toxicity studies // Chem. Res. Toxicol. -

2007. - V.20, N.6. - P.854-858.

50. Dellinger A., Zhou Z., Connor J. et al. Application of fullerenes in nanomedicine: an update. // Nanomedicine (Lond). - 2013. - Vol.8, N.7. - P.1191-208.

51. Doi Y., Ikeda A., Akiyama M. et al. Intracellular uptake and photodynamic activity of water-soluble [60] and [70]fullerenes incorporated in liposomes // Chemistry. -

2008. - V.12.

52. Dukhin A.S., Goetz P.J. Characterization of liquids, nano- and microparticulates and porous bodies using ultrasound // Studies in interface science, Vol.24. - 2010. - Amsterdam et al.: Elsevier.

53. Dunk P.W., Adjizian J.J., Kaiser N.K. et al. Metallofullerene and fullerene formation from condensing carbon gas under conditions of stellar outflows and implication to stardust // Proc. Natl. Acad. Sci. USA. - 2013. - Vol. 110, N.45. - P.18081-18086.

54. Fang J., Lyon D.Y., Wiesner M.R. et al. Effect of a fullerene water suspension on bacterial phospholipids and membrane phase behavior // Environ Sci. Technol. - 2007. - V.41, N.7. - P.2636-2642.

55. Faulstich H., Zobeley S., Rinnerthaler G. et al. Fluorescent phallotoxins as probes for filamentous actin // Journal of muscle research and cell motility. - 1988. - Vol. 9, N.5. - P. 370-383.

56. Fiorito S., Serafino A., Andreola F., Bernier P. Effects of fullerenes and single wall carbon nanotubes on murine and human macrophages // Carbon. - 2006. - Vol.44. - P.1100-1105.

57. Gao J., Wang H.L., Shreve A. et al. Fullerene derivatives induce premature senescence: a new toxicity paradigm or novel biomedical applications // Toxicol Appl Pharmacol. - 2010. - Vol.244, N.2. - P.130-143.

58. Gharbi N., Pressac M., Hadchouel M. et al. [60]Fullerene is an in vivo powerful antioxidant with no acute or sub acute toxicity // Nano Letters. - 2005. - V.5. - P.2578­2585.

59. Gelderman M.P., Simakova O., Clogston J.D. et al. Adverse effects of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro // Int. J. Nanomedicine. - 2008. - N.3. - P. 59-68.

60. Gitsov I., Simonyan A., Wang L. et al Polymer-Assisted Biocatalysis: Unprecedented Enzymatic Oxidation of Fullerene in Aqueous Medium // J. Polymer Sci. Part A. - 2011. - Vol.50. - №1. - P.119-126.

61. Gmoshinski I.V., Khotimchenko S.A., Popov V.O. et al. Nanomaterials and nanotechnologies: methods of analysis and control // Russian Chemical Reviews. - 2013. - Vol.82, N.1. - P.48-76.

62. Golub A., Matyshevska O., Prylutska S. et al. Fullerenes immobilized at silica surface: topology, structure and bioactivity // J. Mol. Liquids. - 2003. - V.105, N.2-3. - P.141-147.

63. Grebowski J., Kazmierska P., Krokosz A. Fullerenols as a New Therapeutic Approach in Nanomedicine // Biomed Res Int. - 2013. - ID 751913.

64. Grabowski J., Kazmierska P., Krokosz A. Fullerenol - properties and applications in biomedical sciences // Postepy Hig Med Dosw (Online). - 2013. - N.67. - P.859­872.

65. Griendling K.K., Minieri C.A., Ollerenshaw J.D. et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells // Circ Res. - 1994. - Vol.74. - P. 1141-1148.

66. Gupta S.K., Dhawan A., Shanker R. In silico approaches: prediction of biological targets for fullerene derivatives // J Biomed Nanotechnol. - 2011. - Vol.7, N.1. P.91-2.

67. Henry T.B., Menn F.M., Fleming J.T. et al. Attributing effects of aqueous C60 nano-aggregates to tetrahydrofuran decomposition products in larval zebrafish by assessment of gene expression // Environ. Health. Perspect. - 2007. - V.115, N.7. - P.1059-1065.

68. Hirsch A. Principles of Fullerene Reactivity // Topics in Current Chemistry. - Vol.199. - 1999. - P.1-65.

69. Hu Z., Guan W., Wang W. et al. Protective effect of a novel cystine C60 derivative on hydrogen peroxide-induced apoptosis in rat pheochromocytoma PC12 cells // Chem. Biol. Interact. - 2007. - V.167, N.2. - P.135-144.

70. Hu Z., Guan W., Wang W. et al. Synthesis of beta-alanine C60 derivative and its protective effect on hydrogen peroxide-induced apoptosis in rat pheochromocytoma cells // Cell Biol. Int. - 2007. - V.31, N.8. - P.798-804.

71. Huang Z.J., Haugland R.P., You W.M. et al. Phallotoxin and actin binding assay by fluorescence enhancement // Analytical biochemistry. - 1992. - Vol.200, N.1. - P. 199­204.

72. Injac R., Boskovic M., Perse M. et al. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress // Pharmacol. Rep. - 2008. - Vol.60, N.5. - P.742-749.

73. Injac R., Perse M., Cerne M. et al. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer // Biomaterials. - 2009. - N.30. - P. 1184-1196.

74. Injac R., Radic N., Govedarica B. et al. Bioapplication and activity of fullerenol C60(OH)24 // African J. of Biotechnology. - 2008. - Vol.7, N.25. - P.4940-4050.

75. Injac R., Radic N., Govedarica B. et al. Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C60(OH)24 through inhibition of oxidative stress // Pharmacol. Rep. - 2009. - N.61. - P. 335-342.

76. Irie K., Nakamura Y., Ohigashi H. et al. Photocytotoxicity of water-soluble fullerene derivatives // Biosci. Biotechnol. Biochem. - 1996. - V.60. - P. 1359-1361.

77. Isaacson C.W., Usenko C.Y., Tanguay R.L., Field J.A. Quantification of fullerenes by LC/ESI-MS and its application to in vivo toxicity assays // Anal. Chem. - 2007. - V.79, N.23 - P.9091-9097.

78. Isakovic A., Markovic Z., Todorovic-Markovic B. et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene // Toxicol. Sci. - 2006. - V.91, N.1. - P.173-83.

79. Jani P., Halbert G.W., Langridge J. et al. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency // Pharm. Pharmacol. - 1990. - Vol.42. - P.821-826.

80. Johnston H.J., Hutchison G., Christensen F.M. et al. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological

mechanisms responsible for the observed toxicity. // Crit Rev Toxicol. - 2010. - Vol.40, N.4. - P.328-346.

81. Kamat J.P., Devasagayam T.P., Priyadarsini K.I. et al. Oxidative damage induced by the fullerene C60 on photosensitization in rat liver microsomes // Chem. Biol. Interact. - 1998. - V.114, N.3. - P.145-159.

82. Kapuscinski J. // Biotechnic & histochemistry: official publication of the Biological Stain Commission. - 1995. - Vol.70, N.5. - P. 220-233.

83. Kato H., Shinohara N., Nakamura A. et al. Characterization of fullerene colloidal suspension in a cell culture medium for in vitro toxicity assessment // Mol Biosyst. - 2010. - Vol.6, N.7. - P. 1238-1246.

84. Kato S., Aoshima H., Saitoh Y. et al. Biological safety of liposome-fullerene consisting of hydrogenated lecithin, glycine soja sterols, and fullerene-C60 upon photocytotoxicity and bacterial reverse mutagenicity // Toxicol. Ind. Health. - 2009. - Vol.25, N.3.- P.197-203.

85. Kato S., Aoshima H, Saitoh Y. et al. Defensive effects of fullerene-C60 dissolved in squalane against the 2,4-nonadienal-induced cell injury in human skin keratinocytes HaCaT and wrinkle formation in 3D-human skin tissue model // J Biomed Nanotechnol. - 2010. - Vol.6, N.1. - P.52-58.

86. Kato S., Aoshima H., Saitoh Y. et al. Fullerene-C60/liposome complex: Defensive effects against UVA-induced damages in skin structure, nucleus and collagen type I/IV fibrils, and the permeability into human skin tissue // J Photochem Photobiol B. - 2010. - Vol.98, N.1. - P.99-105

87. Kato S., Aoshima H., Saitoh Y. et al. Highly hydroxylated or gamma- cyclodextrin-bicapped water-soluble derivative of fullerene: the antioxidant ability assessed by electron spin resonance method and beta-carotene bleaching assay // Bioorg. Med. Chem. Lett. - 2009. - Vol. 19, N.18. - P.5293-5296.

88. Kato S., Taira H., Aoshima H. et al. Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics // J Nanosci Nanotechnol. - 2010 - Vol.10, N.10. - P.6769-74.

89. Kim K.T., Jang M.H., Kim J.Y. et al. Embryonic toxicity changes of organic nanomaterials in the presence of natural organic matter // Sci Total Environ. - 2012. - Vol.426. - P.423-9.

90. Klaper R., Crago J., Barr J. et al. Toxicity biomarker expression in daphnids exposed to manufactured nanoparticles: changes in toxicity with functionalization // Environ. Pollut. - 2009. - Vol.157, N.4. - P.1152-1156.

91. Kong L., Zepp R.G. Production and consumption of reactive oxygen species by fullerenes // Environ Toxicol Chem. - 2012. - Vol.31, N.1. - P.136-143.

92. Koni P.A., Joshi S.K., Temann U.A. et al. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow // The Journal of experimental medicine. - 2001. - V. 193. - N.6. - P.741-754.

93. Kraszewski S., Tarek M., Treptow W. et al. Affinity of C(60) neat fullerenes with membrane proteins: a computational study on potassium channels // ACS Nano. - 2010. - Vol.4, N.7. - P.4158-4164.

94. Kuroda Y., Nozawa H., Ogoshi H. Kinetic behavior of solubilization of C60, into water by complexation with γ-cyclodextrin // Chem. Lett. - 1995. - P.47-48.

95. Kutner W., Boulas P., Kadish K.M. Solubilization of buckminsterfullerene, C60, in water and some polar organic solvents by cytodextrin inclusion chemistry // J. Electrochem. Soc. - 1992. - V.139. - P.243.

96. Labuzek K., Gorki K., Jaroszek H. et al. Highly Organized Nanostructures for Brain Drug Delivery - New Hope or Just a Fad? // CNS Neurol Disord Drug Targets. - 2013 Aug. 27 [Epub ahead of print].

97. Landa P., Vankova R., Andrlova J. et al. Nanoparticle-specific changes in Arabidopsis thaliana gene expression after exposure to ZnO, TiO2, and fullerene soot. // J. Hazard Mater. - 2012. - Vol.30, N.241- 242. - P.55-62

98. Lin A.M., Chyi B.Y., Wang S.D. et al. Carboxyfullerene prevents iron-induced oxidative stress in rat brain // J. Neurochem. - 1999. - V.72, N.4. - P. 1634-1640.

99. Liu Y., Jiao F., Qiu Y. et al. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity // Biomaterials. - 2009. - Vol.30, N.23- 24. - P.3934-3945.

100. Lovern S.B., Klaper R. Daphnia magna mortality when exposed to titanium dioxide and fullerene (C60) nanoparticles // Environ Toxicol. Chem. - 2006. - V.25, N.4. - P.1132-1137.

101. Ma X., Bouchard D. Formation of aqueous suspensions of fullerenes // Environ. Sci. Technol. - 2009. - Vol.43, N.2. - P.330-336.

102. Maeda R., Noiri E., Isobe H. et al. A water-soluble fullerene vesicle alleviates angiotensin II-induced oxidative stress in human umbilical venous endothelial cells // Hypertens. Res. - 2008. - V.31, N.1. - P.141-151.

103. McQualter J.L., Brouard N., Williams B. et al. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction // Stem cells. - 2009. - V.27. - N.3. - P.623-633.

104. Medrek M., Plucinski F., Mazurek A.P. Endohedral complexes of fullerene C60 with small convalent molecules (H2O, NH3, H2, 2H2, 3H2, 4H2, O2, O3) in the context of potential drug transporter system // Acta Pol. Pharm. - 2013. - Vol.70, N.4. - P.659-65.

105. Michalitsch R., Kallinger C., Verbandt Y. et al. The Fullerene Patent Landscape in Europe // Nanotechnology Law & Business. - 2008. - Vol.5, N.1. - P.85-94.

106. Montanez M.I., Ruiz-Sanchez A.J., Perez-Inestrosa E. A perspective of nanotechnology in hypersensitivity reactions including drug allergy // Curr Opin Allergy Clin. Immunol. - 2010. - Vol.10, N.4. - P.297-302.

107. Moriguchi Т., Yano K., Hokari S., Sonoda M. Effect of repeated application of C60 combined with UVA radiation onto hairless mouse back skin // Full. Sci. Technol.

- 1999. - V.7. - P.195-202.

108. Morimoto Y., Hirohashi M., Ogami A. et al. Inflammogenic effect of well- characterized fullerenes in inhalation and intratracheal instillation studies // Part Fibre Toxicol. - 2010. - Vol.7, N.4.

109. Morton D.B., Abbot D., Barelay R. et al. Removal of blood from laboratory mammals and birds // Laboratory animals. - 1993. - Vol. 27. - P.1-22.

110. Moussa F., Chretien P., Dubois P. et al. The influence of C60 powders on cultured human leukocytes // Full. Sci. Techno. - 1995. - V.3. - P.333-342.

111. Moussa F., Chretien P., Pressac M., et al. Preliminary study of the influence of cubic С60 on cultured human monocytes: lack of interleikin-1B secretion // Full. Sci. Technol. - 1997. - V.5. - P.503-510.

112. Moussa F., Pressac M., Chretien P. et al. C60 fullerene toxicity: preliminary account of an in vivo study // Abstracts of Joint International Meeting the Electrochemical Society and the International Society of Electrochemistry. - 1997. - V.97, N.2. - P.1589.

113. Moussa F., Pressac M., Genin E. et al. Quantitative analysis of C60 fullerene in blood and tissues by high- performance liquid chromatography with photodiode-array and mass spectrometric detection // J. Chromatogr. B. Biomed. Sci. Appl. - 1997. - Vol. 696, N.1. - P.153-159.

114. Moussa F., Roux S., Pressac M. et al. In vivo reaction between [60] fullerene and vitamin A in mouse liver // New J. Chem. - 1998. - Vol.22. - P.989-992.

115. Moussa F., Trivin F., Ceolin R. et al. Early effects of C60 administration in Swiss mice: a preliminary account for in vivo C60 toxicity // Full. Sci. Technol. - 1996. - V.4. - P.21-29.

116. Mrdanovic J., Solajic S., Bogdanovic V. et al. Effects of fullerenol C60(OH)24 on the frequency of micronuclei and chromosome aberrations in CHO-K1 cells // Mutat. Res. - 2009. - Vol.680, N. 1- 2. - P.25-30.

117. Mroz P., Pawlak A., Satti M. et al. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism // Free Radic. Biol. Med. - 2007. - V.43, N.5. - P.711-719.

118. Murakami M, Hyodo S, Fujikawa Y et al. Photoprotective effects of inclusion complexes of fullerenes with polyvinylpyrrolidone // Photodermatol Photoimmunol Photomed. - 2013. - V.29, N.4. - P.196-203.

119. Navarro D.A., Kookana R.S., Kirby J.K. Behaviour of fullerenes (C60) in the terrestrial environment: potential release from biosolids-amended soils // J Hazard Mater. - 2013. - Vol.262. - P.496-503.

120. Nelson M.A., Domann F.E., Bowden G.T. et al. Effects of acute and subchronic exposure of topically applied fullerene extracts on the mouse skin // Toxicol. Ind. Health. - 1993. - V.9, N.4. - P.623-630.

121. Newman P.J. The biology of PECAM-1 // The Journal of clinical investigation. - 1997. - V.99. - N.1. - P.3-8.

122. Nikolic N., Vranjes- Duric S., Jankovic D. et al. Preparation and biodistribution of radiolabeled fullerene C60 nanocrystals // Nanotechnology. - 2009. - Vol. 20, N.38. - P.385102.

123. Oberdorster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass // Environ. Health. Perspect. - 2004. - V.112, N.10. - P.1058-1062.

124. Oberdorster E., Zhu S., Blickley T.M. et al. Ecotoxicology of carbon-based engineered nanoparticles: Effects of fullerene (C60) on aquatic organisms // Toxicology of Carbon Nanomaterials. - 2006. - Vol.44, N.6. - P.1112-1120.

125. Oberdorster G., Sharp Z., Elder A.P. et al. Translocation of inhaled ultrafine particles to the brain // Inhal. Toxicol. - 2004. - V.16, N.4. - P.437-445.

126. Panina L.K., Kurochkin V.E., Bogomolova E.V. et al. Biotransformation of Fullerenes // Doklady Biological Sciences. - 1997. - Vol.357. - N.2. - P.530-532.

127. Park E.J., Kim H., Kim Y. et al. Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. // Toxicol. Appl. Pharmacol. - 2010. - Vol.244, N.2. - P.226-233.

128. Piotrovsky L.B. Biological activity of pristine fullerene C60 // Carbon Nanotech. / Ed. L. Dai: Elsevier. - 2006. - P.235-253.

129. Porter A., Gass M., Muller K. et al. Visualizing the uptake of C60 to the cytoplasm and nucleus of human monocytederived macrophage cellsusing energy- filtered transmissionelectron microscopy and electrontomography // Environ. Sci. Technol. - 2007. - V.41, N.8. - Р.3012-3017.

130. Porter A.E., Muller K., Skepper J. et al. Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution

electron microscopy and electron tomography // Acta. Biomater. - 2006. - V.2, N.4. - P.409-419.

131. Popov A. A., Shangfeng Y., Dunsch L.. Endohedral Fullerenes // Chem. Rev. - 2013. - 113(8). - P.5989-6113

132. Priyadarsini K.I., Monan H., Tyagi A.K., Mittai J.P. Inclusion complex of γ- cyclodextrin-C60: formation, characterization, and photo-physical properties in aqueous solution // J. Phys. Chem. - 1994. - V.98. - P.4756-4759.

133. Pycke B.F., Benn T.M., Herckes P. et al. Strategies for quantifying C(60) fullerenes in environmental and biological samples and implications for studies in environmental health and ecotoxicology // Trends Analyt. Chem. - 2011. - Vol.30, N.1.

- P.44-57.

134. Qiao R., Roberts A.P., Mount A.S. et al. Translocation of C60 and its derivatives across a lipid bilayer // Nano Lett. - 2007. - V.7, N.3. - P.614-619.

135. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet // J Nutr. - 1993. - Vol. 123, N.11. - P.1939-51.

136. Rieux A., Fievez V., Theate I. et al. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells // Eur. J. Pharm. Sci. - 2007. - Vol.30, N.5. - P.380- 391.

137. Richmond R. C., Gibson U.J. Fullerene coated surfaces and uses thereof. - US Patent № 5.310.669. - 1994.

138. Roberts J.E., Wielgus A.R., Boyes W.K. et al. Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells // Toxicol. Appl. Pharmacol. - 2008. - V.228, N.1. - P.49-58.

139. Rud Y., Buchatskyy L., Prylutskyy Y. et al. Using C60 fullerenes for photodynamic inactivation of mosquito iridescent viruses // J Enzyme Inhib Med Chem.

- 2012. - Vol.27, N.4. - P.614-617.

140. Saitoh Y., Miyanishi A., Mizuno H. et al. Super-highly hydroxylated fullerene derivative protects human keratinocytes from UV-induced cell injuries together with the

decreases in intracellular ROS generation and DNA damages // J. Photochem. Photobiol. - 2011. - Vol.102, N.1. - P.69-76.

141. Sakai A., Yamakoshi Y.N., Miyata N. The effects of fullerenes on the initiation and promotion stages of BALB/3T3 cell transformation // Full. Sci. Technol. - 1995. - V.3. - P.377-388.

142. Sayes C.M., Gobin A.M., Ausman K.D. et al. Nano-C60 cytotoxicity is due to lipid peroxidation // Biomaterials. - 2005. - V.26, N.36. - P.7587-7595.

143. Sayes C.M., Marchione A. A., Reed K.L., Warheit D.B. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles // Nano. Lett. - 2007. - V.7, N.8. - P.2399-2406.

144. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles // Toxicol. Sci.

- 2007. - V.97, N.1. - P.163-180.

145. Scrivens W.A., Tour J.M., Creek K.E., Pirisi L. Synthesis of 14C-labeled C60, its suspension in water and its uptake by human keratinocytes // J. Am. Chem. Soc. - 1994.

- V.116. - P.4517-4518.

146. Semenov K.N., Charykov N.A., Keskinov V.N. Fullerenol synthesis and identification. Properties of the fullerenol water solutions // J. Chem. Eng. Data. - 2011.

- Vol.56, N.2. - P.230-239.

147. Sera N., Tokiwa H., Miyata N. Mutagenicity of the fullerene C60-generated singlet oxygen dependent formation of lipid peroxides // Carcinogenesis. - 1996. - V.17, N.10.

- P.2163-2169.

148. Silva G.A. Neuroscience nanotechnology: progress, opportunities and challenges // Nat. Rev. Neurosci.- 2006. - N.7. - P. 65-74.

149. Silva G.A. Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system // Surg. Neurol. - 2005. - N.63. - P.301-306.

150. Shoji M., Takahashi E., Hatakeyama D. et al. Anti-Influenza Activity of C60 Fullerene Derivatives // PLoS ONE. - 2013. - Vol.8, N.6. - P.e66337.

151. Spohn P., Hirsch C., Hasler F. et al. C60 fullerene: a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays // Environ. Pollut. - 2009. - Vol.157, N.4. - P. 1134-1139.

152. Spurlin T.A., Gewirth A.A. Effect of C60 on solid supported lipid bilayers // Nano Lett. - 2007. - V.7, N.2. - P.531-535.

153. Srdjenovic B., Milic-Torres V., Grujic N. et al. // Toxicol. Mech. Methods. - 2010. - Vol. 20, N.6. - P.298-305.

154. Steffensen I.L., Alexander J., Binderup M.L. et al. Opinion of the Panel on Food

Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics of the Norwegian Scientific Committee for Food Safety. Evaluation of an application to use fullerene C60 as a food additive. [Электронный ресурс] 17.12.2010. Doc. no.: 10­406-5 final. ISBN: 978-82-8259-010-5. URL:

http://www.vkm.no/dav/732f564c58.pdf

155. Stuart C.A., Twistelton R., Nicholas M.K. et al. Passage of cow’s milk proteins in breast milk // Clin.Allergy. - 1984. - Vol.14, N6. - P.533-535.

156. Su Y., Xu J.Y., Shen P. et al. Cellular uptake and cytotoxic evaluation of fullerenol in different cell lines // Toxicology. - 2010. - Vol.269, N.2-3. - P.155-159.

157. Takahashi M., Kato H., Doi Y. et al. Sub-acute oral toxicity study with fullerene C60 in rats // The Journal of Toxicological Sciences. - 2012. - Vol.37, N.2. - P.353­361.

158. Theriot C.A., Casey R.C., Moore V.C. et al. Dendro[C(60)]fullerene DF-1 provides radioprotection to radiosensitive mammalian cells // Radiat Environ Biophys. - 2010. -Vol.49, N.3. - P.437-445.

159. Trajkovic S., Dobric S., Jacevic V. et al. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats // Colloids. Surf B. Biointerfaces. - 2007. - V.58, N.1. - P.39-43.

160. Tsai M.C., Chen Y.H.., Chiang L.Y. Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide- elicited changes in rat hippocampus in vitro // J. Pharm. Pharmacol. - 1997. - V.49, N.4. - P.438-445.

161. Tsuchiya T., Oguri I., Yamakoshi Y.N., Miyata N. Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo // FEBS Lett. - 1996. - V.393, N.1. - P.139-145.

162. Tsuchiya T., Yamakoshi Y.N., Miyata N. A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limd bud cell culture system // Biochem. Biophys. Res. Commun. - 1995. - V.206. - P.885-894.

163. Turner J.R. Molecular Basis of Epithelial Barrier Regulation: From Basic Mechanisms to Clinical Application // The American Journal of Pathology. - 2006. - V.169, N.6. - P.1901-1909.

164. Ueng T.H., Kang J.J., Wang H.W. et al. Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60 // Toxicol. Lett. - 1997. - V.93, N.1. - P.29-37.

165. Usenko C.Y., Harper S.L., Tanguay R.L. Fullerene C60 exposure elicits an oxidative stress response in embryonic зебрафиш // Toxicol. Appl. Pharmacol. - 2008. - V.229, N.1. - P.44-55.

166. Usenko C.Y., Harper S.L., Tanguay R.L. In vivo evaluation of carbon fullerene toxicity using embryonic zebrafish // Carbon N.Y. - 2007. - V.45, N.9. - P.1891-1898.

167. Volkheimer G. Persorption of particles: physiology and pharmacology // Adv. Pharmacol. Chemother. - 1977. - Vol.14. - P.163-187.

168. Wang H.M., Wenz G. Molecular solubilization of fullerene C60 in water by γ- cyclodextrin thioethers // Beilstein J. Org. Chem. - 2012. - Vol.8. - P. 1644-1651.

169. Wang N., Bao X., Yang C. et al. Design and synthesis of indole-substituted fullerene derivatives with different side groups for organic photovoltaic devices // Organic Electronics. - 2013. - Vol.14, N.2. - P.682-692.

170. Wielgus A.R., Zhao B., Chignell C.F. et al. Phototoxicity and cytotoxicity of fullerol in human retinal pigment epithelial cells // Toxicol Appl Pharmacol. - 2010. - Vol.242, N.1. - P.79-90.

171. Wiewrodt R., Thomas A.P., Cipelletti L. et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells // Blood. - 2002. - V.99.

- N.3. - P.912-922.

172. Wyder L., Vitaliti A., Schneider H. et al. Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels // Cancer Research. - 2000. - V.60. - N.17. - P.4682-4688.

173. Xia X.R., Monteiro- Riviere N.A., Riviere J.E. Intrinsic biological property of colloidal fullerene nanoparticles (nC60): lack of lethality after high dose exposure to human epidermal and bacterial cells // Toxicol Lett. - 2010. - Vol.197, N.2. - P.128­134.

174. Xiao L., Takada H., Maeda K. et al. Antioxidant effects of water-soluble fullerene derivatives against ultraviolet ray or peroxylipid through their action of scavenging the reactive oxygen species in human skin keratinocytes // Biomed. Pharmacother. - 2005.

- V.59. - P.351-358.

175. Xu X., Wang X., Li Y. et al. A large-scale association study for nanoparticle C60 uncovers mechanisms of nanotoxicity disrupting the native conformations of DNA/RNA // Nucleic Acids Res. - 2012. - Vol. 40, N.16. P.7622-32.

176. Yamago S., Tokuyama H., Nakamura E. et al. In vivo biological behavior of a water- miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity // Chem. Biol. - 1995. - V.2, N.6. - P.385-389.

177. Yamawaki H., Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells // Am. J. Physiol. Cell. Physiol. - 2006. - V.290, N.6. - P.1495-1502.

178. Yamakoshi Y.N., Yagami Т., Fukuhara K. et al. Solubilization of fullerenes into water with polyvinyl-pyrrolidone applicable to biological tests // J. Chem. Soc. - 1994.

- P.517-518.

179. Yang X., Ebrahimi A., Li J. et al. Fullerene-biomolecule conjugates and their biomedicinal applications // Int J Nanomedicine. - 2014. - Vol.9. - P.77-92.

180. Yin J.J., Lao F., Meng J. et al. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger // Mol. Pharmacol. - 2008. - N. 74. - P. 1132-1140.

181. Yizhak M., Smith A.L., Korobov M.V. et al. Solubility of C60 Fullerene // J. Phys. Chem. - 2001. - Vol.105. - N.13. - P.2499-2506.

182. Yue F.N., Luo S.M., Zhang C.D. Degradation and transformation of engineering carbon nanomaterials in the environment: A review // Ying Yong Sheng Tai Xue Bao. - 2013. - Vol.24, N.2. - P.589-96.

183. Yumita N., Iwase Y., Imaizumi T. et al. Sonodynamically-induced anticancer effects by functionalized fullerenes. // Anticancer Res. - 2013. - Vol. 33, N.8. - P.3145-51.

184. Zha Y.Y., Yang B., Tang M.L. et al. Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability. // Int. J. Nanomedicine. - 2012. - Vol.7. - P.3099-109.

185. Zhang B., Cho M., Fortner J.D. et al. Delineating oxidative processes of aqueous C60 preparations: role of THF peroxide // Environ. Sci. Technol. - 2009. - Vol.43, N.1. - P.108-113.

186. Zhang D.D., Liang Q., Chen J.W. et al. Studies of γ-cyclodextrin inclusion complexes with C60. Supramolec // Chem. - 1994. - V.3. - P.235-239.

187. Zhao B., He Y.Y., Bilski P.J. et al. Pristine (C60) and hydroxylated [C60(OH)24] fullerene phototoxicity towards HaCaT keratinocytes: type I vs type II mechanisms // Chem. Res. Toxicol. - 2008. - V.21, N.5. - P.1056-1063.

188. Zhao B., He Y.Y., Chignell C.F. et al. Difference in phototoxicity of cyclodextrin complexed fullerene [(gamma-CyD)2/C60] and its aggregated derivatives toward human lens epithelial cells // Chem. Res. Toxicol. - 2009. - Vol.22, N.4. - P.660-667.

189. Zhao X., Striolo A., Cummings P. C60 binds to and deforms nucleotides // Biophys. J. - 2005. - V.89, N.6. - P.3856-3862.

190. Zhao Q.F., Zhu Y., Ran T.C. et al. Cytotoxicity of fullerenols on Tetrahymena pyriformis // Nucl. Sci. Techniq. - 2006. - N.17. - P.280-284.

191. Zhu S., Oberdorster E., Haasch M.L. Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnow // Mar. Environ. Res. - 2006. - 62 Suppl. - P.S5-9.

192. Zhu X.S., Zhu L., Lang Y.P. et al. Oxidative damages of long-term exposure to low level fullerenes (C60) in Carassius auratus // Huan. Jing. Ke. Xue. - 2008. - Vol. 29, N.4. - P.855-861.

193. Zhu X., Zhu L., Lang Y. et al. Oxidative stress and growth inhibition in the freshwater fish Carassius auratus induced by chronic exposure to sublethal fullerene (C60) aggregates // Environ. Toxicol. Chem. - 2008. - Vol. 27, N.9. - P. 1979-1985.

194. Zhu X., Zhu L., Li Y. et al. Developmental toxicity in zebrafish (Danio rerio) embryos after exposure to manufactured nanomaterials: buckminsterfullerene aggregates (nC60) and fullerol // Environ Toxicol. Chem. - 2007. - Vol. 26, N.5. - P.976-979.